Medpace Holdings (MEDP) Net Cash Flow (QoQ) (2016 - 2026)
Medpace Holdings (MEDP) Net Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -195.25% |
| Mar 31, 2026 | -25.22% |
| Dec 31, 2025 | -11.74% |
| Sep 30, 2025 | 160.03% |
| Jun 30, 2025 | -72.98% |
| Mar 31, 2025 | -1,687.56% |
| Dec 31, 2024 | -89.99% |
| Sep 30, 2024 | 38.93% |
| Jun 30, 2024 | -35.98% |
| Mar 31, 2024 | 8.64% |
| Dec 31, 2023 | 165.58% |
| Sep 30, 2023 | 791.89% |
| Jun 30, 2023 | -145.61% |
| Mar 31, 2023 | 589.20% |
| Dec 31, 2022 | 53.14% |
| Sep 30, 2022 | 79.45% |
| Jun 30, 2022 | 89.93% |
| Mar 31, 2022 | -687.20% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 911.63% |